GRM5 and major depressive disorder: The fact that only one patient exceeded the clinical threshold for depression and four patients for anxiety further reinforces the idea that NET disruptions are more fatigue‐specific, while mGluR5 dysfunction might reflect a shared neurochemical mechanism underlying both fatigue and mood disturbances.